Home
Brooks Laboratories Ltd Share Price History

Brooks Laboratories Ltd
NSE : 21 Feb, 2025
123.820.1 (0.0%)
Prev Close
123.8
Open Price
123.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
23736
Today's High / Low
129.0 / 121.0
52 WK High / Low
198.9 / 73.3
Market Price of Brooks Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Brooks Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
Date | Price | Open | High | Low |
---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
Parameter | |
---|---|
Sales (Cr.) | NaN |
Sales YoY Gr. | - |
Adj EPS | -7.84 |
YoY Gr. | - |
Net Profit (Cr.) | -19 |
BVPS | 32.04 |
Key Financial Parameters
Parameter | |
---|---|
Return on Capital Emp. % | 0 |
Op. Profit Mgn % | 1.62 |
Net Profit Mgn % | -25.09 |
Debt to Equity % | 0.4 |
Latest Shareholding
Promoters Holdings Over Time
About Brooks Laboratories Ltd
- Brooks Laboratories Limited was incorporated on January 23, 2002.
- The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis.
- The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat.
- Both the units are cGMP compliant in conformity with national and international standards.
- The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.
Popular Search
FAQs for Brooks Laboratories Ltd Share Price History
What are the key events that typically impact Brooks Laboratories Ltd's share price history?
Key events that impact Brooks Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Brooks Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Brooks Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Brooks Laboratories Ltd?
Dividends can influence Brooks Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Brooks Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Brooks Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Brooks Laboratories Ltd’s share price history?
To understand Brooks Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.